Daiichi Sankyo to acquire Ambit Biosciences
30 September 2014 | By Daiichi Sankyo
Lead compound, Quizartinib, will further build Daiichi Sankyo oncology pipeline...
List view / Grid view
News
Horizon Discovery Group plc acquires Sage Labs Inc. for $48M (£29M)
29 September 2014 | By Horizon Discovery Group
Horizon Discovery Group plc announced it has agreed to acquire Sage Labs Inc...
Tumour profiling with Caris Molecular Intelligence offers hope for patients with rare cancers by identifying new personalised treatment options
29 September 2014 | By Caris Life Sciences
Caris Life Sciences announced important new data presented at the European Society for Medical Oncology Annual Conference, highlighting how tumour profiling with Caris Molecular Intelligence can help transform cancer care...
Kymab strengthens and expands capabilities through Board appointments and Executive promotions
29 September 2014 | By Kymab
Following a US$40 million Series B investment from The Wellcome Trust and the Bill & Melinda Gates Foundation...
SIGMOID enters into a licence agreement with Pendopharm for commercialisation rights to CyCol® in Canada
29 September 2014 | By SIGMOID PHARMA LIMITED
SIGMOID PHARMA LIMITED and Pendopharm have entered into agreements concerning a licence for exclusive rights to commercialise CyCol® in the Canadian market and an equity investment in SIGMOID...
EATRIS enters framework agreement with Roche to access Europe-wide network of translational researchers
26 September 2014 | By EATRIS
EATRIS has signed a formal framework agreement with the Roche Partnering Extending Innovation Network (EIN) program...
Pfizer completes acquisition of InnoPharma
26 September 2014 | By Pfizer
Pfizer Inc. announced that it has completed its acquisition of the pharmaceutical development company, InnoPharma, Inc., following receipt of United States (U.S.) regulatory approval from all government authorities required by the agreement and other closing conditions...
Guidelines raise standards for contamination control
25 September 2014 | By Ecolab
Recent guidelines aimed at raising standards of contamination control in the pharmaceutical industry mean organisations need to assess their current practices...
SGS announces completion of new life science services laboratory in Carson, California
25 September 2014 | By SGS Life Science Services
SGS Life Science Services announced the the completion of its fifth North American Life Science Services laboratory, in Carson, California...
TxCell financial results for the first half of 2014
25 September 2014 | By TXCELL
TxCell reports its financial results for the first half of 2014...
Horizon Discovery Group plc signs Master Services Agreement for approximately $1.2 million
25 September 2014 | By Horizon Discovery
Agreement covers development of molecular reference standards for companion diagnostics...
Probiodrug announces its intention to launch an Initial Public Offering and listing on Euronext Amsterdam
25 September 2014 | By Probiodrug
Probiodrug AG announces its intention to raise new funds through an Initial Public Offering and listing on Euronext Amsterdam...
nLife Therapeutics receives USD 350,000 from The Michael J. Fox Foundation for Parkinson’s Research
23 September 2014 | By nLife
The funding will help characterize the mechanism of action of nLife’s lead compound NLF-PD-1233 in a Parkinson disease model and find a proper dose to engage clinical development...
DNA in ‘gene deserts’ linked with breast cancer
23 September 2014 | By The Institute of Cancer Research
Even long stretches of DNA that contain no genes at all can affect the risk of breast cancer, by physically interacting with genes elsewhere, a new study reports...
Horizon Discovery Group plc interim results for the six months ended 30 June 2014
23 September 2014 | By Horizon Discovery
Horizon Discovery Group plc announces its interim results for the six months ended 30 June 2014...